Completed PHASE2 INTERVENTIONAL NCT00004340

Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis

Sponsor: National Center for Research Resources (NCRR)

Conditions End Stage Renal Disease Renal Osteodystrophy

Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Jun 30, 1995

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004340, this PHASE2 trial focuses on End Stage Renal Disease and Renal Osteodystrophy and remains completed. Sponsored by National Center for Research Resources (NCRR), it has been updated 5 times since 1995, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Research Resources (NCRR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of California, Los Angeles

Data source: National Center for Research Resources (NCRR)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States